Edwards Lifesciences Corporation held its 2025 Annual Meeting of Stockholders on May 8, 2025. During the meeting, several proposals were presented and approved. These included the election of nine director nominees, the ratification of PricewaterhouseCoopers as the independent registered public accounting firm for 2025, and the approval of the amendment and restatement of the 2001 employee stock purchase plan for US employees to increase the total number of shares of common stock available for issuance by 4.2 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edwards Lifesciences Corporation published the original content used to generate this news brief on May 09, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.